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Mammalian tissues defective in nonsense-
mediated mRNA decay display highly aberrant
splicing patterns
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Abstract
Background: Nonsense-mediated mRNA decay (NMD) affects the outcome of alternative splicing by degrading
mRNA isoforms with premature termination codons. Splicing regulators constitute important NMD targets;
however, the extent to which loss of NMD causes extensive deregulation of alternative splicing has not previously
been assayed in a global, unbiased manner. Here, we combine mouse genetics and RNA-seq to provide the first in
vivo analysis of the global impact of NMD on splicing patterns in two primary mouse tissues ablated for the NMD
factor UPF2.
Results: We developed a bioinformatic pipeline that maps RNA-seq data to a combinatorial exon database,
predicts NMD-susceptibility for mRNA isoforms and calculates the distribution of major splice isoform classes. We
present a catalog of NMD-regulated alternative splicing events, showing that isoforms of 30% of all expressed
genes are upregulated in NMD-deficient cells and that NMD targets all major splicing classes. Importantly, NMD-
dependent effects are not restricted to premature termination codon+ isoforms but also involve an abundance of
splicing events that do not generate premature termination codons. Supporting their functional importance, the
latter events are associated with high intronic conservation.
Conclusions: Our data demonstrate that NMD regulates alternative splicing outcomes through an intricate web of
splicing regulators and that its loss leads to the deregulation of a panoply of splicing events, providing novel
insights into its role in core- and tissue-specific regulation of gene expression. Thus, our study extends the
importance of NMD from an mRNA quality pathway to a regulator of several layers of gene expression.
Background
Alternative splicing (AS) involves the selective inclusion
and exclusion of exons from a nascent pre-mRNA that
results in various combinations of mature mRNAs with
different coding potential and thus protein sequence [1].
Importantly, it has recently been estimated that nearly
95% of all multi-exon genes in the mammalian cell
undergo AS [2,3], suggesting a pivotal role for AS in
regulating and expanding the repertoire of isoforms
expressed. By examining ESTs, it has been proposed
that one-third of all AS isoforms contain a premature
termination codon (PTC) [4], and these are expected to
be targeted for degradation by nonsense-mediated
mRNA decay (NMD). NMD is an mRNA quality control
mechanism, and the primary function of NMD was initi-
ally thought to be in removal of aberrant transcripts
arising from mutations or faulty transcription, mRNA
processing or translation, but it is now evident that
NMD impacts on both diverse physiological processes
[5-7] as well as pathophysiological conditions (reviewed
in [8]). The conserved core components of the NMD
pathway are the UPF1, UPF2 and UPF3A/B proteins,
and mutations or depletion of these factors inactivate
NMD [9,10]. In mammalian cells, PTCs are distin-
guished from normal stop codons by their position rela-
tive to a downstream exon-exon junction, which is
marked by the deposition of the exon junction complex
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[11]. It has been generally established that for a stop
codon to be recognized by the NMD apparatus, it must
be situated at least 50 nucleotides upstream of an exon-
exon boundary (the 50 nucleotides rule) [12]. Thus,
nearly all naturally occurring eukaryotic stop codons are
found downstream of the last intron, thereby rendering
them immune to NMD. Although recent data have
demonstrated that the proximity of the poly(A)-binding
protein (PABP) to the PTC is inversely correlated with
the efficiency of NMD [13,14], the 50 nucleotides rule
applies to almost all studied mammalian transcripts, tak-
ing heed of a few noted exceptions [15,16]. Mechanisti-
cally, AS can utilize NMD to selectively degrade
transcripts by the selective inclusion of a PTC-contain-
ing (PTC+) exon or exclusion of an exon, resulting in a
PTC+ downstream exon. This coupling, initially discov-
ered for serine/arginine-rich (SR) proteins in Caenor-
habditis elegans [17], has been coined regulated
unproductive splicing and translation (RUST) or AS
coupled to NMD (AS-NMD) [4,18]. Intriguingly, pro-
teins involved in splicing processes utilize AS-NMD to
autoregulate their own synthesis through a negative
feedback loop. The most well characterized splicing acti-
vators, the SR proteins, bind to cis elements in the pre-
mRNA, usually stimulating the inclusion of an exon.
The SR proteins have been shown to utilize AS-NMD in
a negative feedback loop to activate the inclusion of a
PTC+ exon (PTC upon inclusion) in their own pre-
mRNA, thus resulting in NMD [18-21]. The other
major class of splice regulators, the heterogeneous
nuclear ribonucleoproteins (hnRNPs), are a class of
RNA binding proteins with roles in mRNA splicing,
export and translation [22,23]. The hnRNPs often, but
not always, bind to splice silencer elements and repress
splicing at nearby splice sites. Splicing repressors, such
as hnRNPs, use AS-NMD to repress the inclusion of a
coding exon in their own pre-mRNA that leads to an
out-of-frame skipping event, consequently inducing a
downstream PTC and thus NMD (PTC upon exclusion).
Moreover, AS-NMD is also used to cross-regulate
expression of other splice factors, as described elegantly
for PTBP1 and PTBP2 [24].
AS is regulated by the selective recruitment of splice
regulators to pre-mRNAs. It is well established that spli-
cing activators (such as SR proteins) compete with spli-
cing repressors (such as hnRNPs) for binding to splice
sites in an antagonistic manner, where the relative con-
centration of the two classes regulates the level of AS
[25,26]. Thus, the fate of an alternative exon is usually
decided by the antagonism between SR proteins and
hnRNPs and their concentration and activity (reviewed
in [27]). Due to the autoregulatory feedback loop
employed by splice regulators, modulating NMD could
potentially have widespread effects on the concentration
of splicing activators and repressors and thus AS and
AS-NMD.
Despite the potential of AS-NMD, it is presently not
known to what extent this pathway regulates the tran-
scriptome on a global scale, and how AS homeostasis is
affected by NMD. A major problem in discovering the
full spectrum of PTC+ transcripts is that EST and
cDNA repositories are biased against these isoforms due
to their unstable nature in normal cells. Additionally,
most studies have primarily focused on microarrays to
query the transcriptome upon muting NMD [18,19,28],
and the newer studies using sequencing [29] have
focused on single cassette exon events, thus disregarding
many other physiologically important splice classes such
as mutually exclusive exons and alternative 5’ and 3’
splice site usage. Last but not least, the transcriptomic
consequences of genetically modulating NMD and
thereby AS in the mammalian organism are largely
unanswered.
In the present study, we have performed RNA-seq on
two different tissues from a Upf2 conditional knock-out
(KO) mouse line. Thus, in addition to providing signifi-
cantly novel insights into common and tissue-specific
functions of NMD, our study represents the first com-
prehensive and unbiased transcriptome analysis of adult
genetically modified mice. To facilitate a high-resolution
analysis of all possible exon-exon combinations, we have
generated a bioinformatic pipeline, named RAINMAN
(RnAseq-based Isoform detection and NMd ANalysis
pipeline; available to the scientific community), that
maps reads to a combinatorial database that incorpo-
rates both known and in silico predicted exon-exon
junctions. The pipeline predicts NMD susceptibility
based on junction evidence and groups AS events into
seven major splice isoform classes. Using this approach,
our results reveal an unprecedented increase in AS
upon ablating UPF2, and by inference NMD (although
small additive effects from UPF3A/B interaction and
deregulation of UPF1 phosphorylation cannot be wholly
excluded from analysis, we juxtapose UPF2 and NMD
ablation for all purposes in this work) and show that a
high proportion of these upregulated AS events are not
predicted to contain a PTC. Hence, we find that only
50% of the increase in AS is directly due to stabilization
of PTC+ isoforms. Our data demonstrate that muting
NMD results in deregulated levels of core splice regula-
tors at both the mRNA and protein level, and further
suggests that this contributes to the deregulation of gen-
eral AS upon ablating NMD. Hence, our data support a
model where NMD ablation leads to deregulated levels
of core splicing factors that ultimately lead to aberrant
global splicing, implying a novel intricate interplay
between the NMD machinery and the splicing factors.
Finally, our data analysis generates the first insights into
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a putative functional role of the PTC and its surround-
ing regions through analysis of their conservation
patterns.
Results
A major task in analyzing AS by RNA-seq is to explore
and quantify the differential representation of various
splice classes and the protein-coding potential of the
mapped reads. To this end, we have developed RAIN-
MAN, a streamlined bioinformatic pipeline available to
the scientific community that maps RNA-seq reads to a
comprehensive combinatorial database of exon-exon
junctions for unique junction discovery, PTC detection
and identification of splice isoforms. We used this pipe-
line to investigate the complexity of the transcriptome
and global role of AS-NMD in vivo in mammalian cells,
by taking advantage of our Upf2 conditional KO mouse,
which we previously used to demonstrate the in vivo
importance of NMD [7,30]. To explore the effect of
NMD on global splicing and to generate and validate an
attractive bioinformatic pipeline to study AS and NMD,
we chose to analyze the transcriptomes of two different
mammalian organ systems with distinct phenotypes
upon UPF2 deletion. In one end of the spectrum, we
analyzed liver, wherein removal of UPF2 results in fail-
ure in liver metabolism and a high mortality rate [30],
and in the other, we analyzed bone marrow-derived
macrophages (BMMs). These macrophages are gener-
ated in vitro from murine bone marrow cells, and Upf2
deleted BMMs are completely devoid of NMD activity
but nevertheless show no morphological or functional
phenotype compared to wild-type (WT) controls [7].
Splice isoform inference and PTC detection
In order to obtain biological material, we first generated
mice in which the NMD core factor Upf2 could be
selectively inactivated in liver or in BMMs using our
previously reported strategy (see Materials and meth-
ods). We performed whole transcriptome sequencing
(single-end) on poly (A)-purified RNA, isolated from
poly-IC injected Upf2fl/fl; Mx1Cre and Upf2fl/fl livers
(termed from now on ‘Liver KO’ and ‘Liver WT’, respec-
tively) and Upf2fl/fl; LysMCre BMMs and Upf2fl/fl BMMs
(henceforth ‘BMM KO’ and ‘BMM WT’, respectively).
In order to minimize biological variation, we generated
libraries from pools of poly(A)-purified RNA derived
from three individual animals. Due to the underrepre-
sented nature of NMD-susceptible transcripts in EST
and cDNA databases [4], we generated a comprehensive
combinatorial database of exon-exon junctions in the
murine genome, using sequences from exon models
annotated in different repositories (RefSeq, Ensembl,
UCSC Known Genes, GENSCAN and Exoniphy;
Supplemental Materials in Additional file 1 and Figure
S1B in Additional file 2). To discover junctions between
exons not previously recorded in the murine transcrip-
tome, we also employed TopHat [31], a de novo map-
ping algorithm, to map reads to junctions between
unannotated exons (Table S1 in Additional file 1). To
utilize reads that cover three or more exons, thus align-
ing to two or more exon-exon junctions, and not initi-
ally mapped to our combinatorial database or by
TopHat, we incorporated an extra read truncation step
(Figure S1B in Additional file 2), trimming reads in
steps of 10 bp and remapping, allowing us to recover an
additional 4 to 7% of total reads. As a result, 84% of
reads mapped to the genome or transcriptome, and out
of these, 28% mapped to splice junctions (Figure 1a),
corresponding to a combined total of 323,474 unique
splice junctions across our two tissues and two geno-
types. With a minimum requirement of three reads to a
splice junction, minimizing sequencing and mapping
artifacts, we mapped approximately 150,000 unique
junctions. Of note, we found that the de novo mapper
TopHat contributed significantly to our transcriptome
set, with 11 to 16% of all discovered junctions uniquely
defined by TopHat (Table S1 in Additional file 1). Map-
ping of the KO samples benefited the most from these
TopHat predicted splice junctions, suggesting that the
curated transcript repositories are biased against the
TopHat-predicted junctions due to their NMD suscept-
ibility. Indeed, TopHat identified 20% and 24% of the
PTC+ splice junctions above our minimum read cutoff,
compared to only 4% and 11% of PTC- splice junctions
(junctions that do result in the generation of a PTC, in
BMM and liver samples, respectively (Table S2 in Addi-
tional file 1). These data demonstrate that at least a
quarter of NMD susceptible transcripts are not present
in the normal murine repositories. This has implications
for future splice isoform detection, since many tran-
scripts that are below detectable levels under physiologi-
cal conditions, and hence are absent in the repositories,
will not be detected under conditions that could favor
their presence, for example, perturbed or disease states.
Thus, taking advantage of our combinatorial database
that includes a pipeline for splice isoform detection and
PTC prediction is likely to considerably increase the
number of isoforms detected under conditions that
favor increased AS.
In the next step of RAINMAN, the pipeline calculates
the distribution of seven different splice isoform classes
and predicts PTCs (see Supplementary Methods in
Additional file 1 for details), and all data are combined
for easy visualization and data mining. An illustrative
example of a genome browser output from the mapping
steps is shown in Figure 1b, with the conditional Upf2
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KO gene deleted for exons 2 and 3 in the KO sample.
The UCSC-based visualization includes both evidence of
reads mapped to junctions and to exons, and, in this
case, demonstrates increased AS in the liver KO com-
pared to WT.
We mapped a total of 150,000 unique junctions with
approximately 100,000 and 130,000 junctions in BMM
and liver tissues, respectively (minimum of three reads
to a junction; Figure 2a, top, and data not shown). Tally-
ing up, we found that 6,256 and 7,997 unique genes har-
bored 14,056 and 25,534 upregulated junction events in
BMM and liver, respectively, an average of 2.3 and 3.2
upregulated junction events per gene (Figure 2a),
demonstrating that loss of UPF2, and by inference
NMD, leads to a substantial deregulation of splicing.
Ablating NMD results in significant upregulation of PTC+
junctions
It has been shown that a stop codon is generally recog-
nized as a PTC by the NMD machinery, if it is situated
at least 50 nucleotides upstream of an exon-exon junc-
tion, termed the 50 nucleotides rule. We assayed and
verified this distance requirement by simply plotting the
position of RefSeq gene model stop codons that reside
in the penultimate exon (Figure S2 in Additional file 3),
observing that the vast majority of these stops indeed
fall precisely within 50 nucleotides of the final intron
boundary, and thereby avoiding the elicitation of NMD
for those transcripts. Incorporating this distance metric
in our PTC prediction algorithm, we calculated the frac-
tion of regulated PTC+ junctions as a function of UPF2
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Figure 1 Mapping and downstream analysis of RNA-seq data. (a) Total number of RNA-seq reads mapped to exonic, junction, intronic and
intergenic regions as well as the fraction of mapped reads for all four samples. Pie charts below visualize the distribution of all mapped reads.
(b) An example of an output from the pipeline, visualized in the UCSC genome browser, showing the Upf2 gene locus, with junctions supported
by reads (horizontal bars in each sub-window), and exon coverage (vertical bars). Refer to Figure S1 in Additional file 2 for another example of a
genome browser output. No minimum read cutoff was used for junction visualization. The very low exon coverage present for knocked out
exons 2 and 3 in KO samples represents a miniscule amount of non-recombined tissue/cells.
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ablation. As expected, this analysis demonstrated a
highly significant upregulation of PTC+ junctions in the
KO samples (Figure 2a, all junctions versus PTC+ junc-
tions, P-value 1 × 10-16, Chi-square). In total, approxi-
mately 44% of predicted PTC+ junctions were
upregulated in BMMs and Liver KO (Figure 2a),
amounting to 16% (BMM) and 28% (liver) of expressed
genes containing at least one NMD-susceptible splice
junction regulated more than two-fold.
Among the upregulated PTC+ splice junctions, 516
were shared between the two tissues, and these corre-
sponded to 448 unique genes (Figure 2a; Table S3 in
Additional file 4), which we thus termed core NMD tar-
gets. The group includes well-known NMD targets such
as Smg5, Hsf1, and Zcchc6 as well as many known
NMD-susceptible splicing factors [6,18,19]. Indeed,
Gene Ontology (GO) analysis demonstrated that the
highest ranked cluster contained genes involved in
mRNA processing and splicing (P-value of 9.0 × 10-18,
Bonferroni corrected; see the full list of GO terms and
genes in Table S3 in Additional file 4). All classical SR
proteins have been shown to utilize AS-NMD to autore-
gulate their own synthesis [20], and our finding that
common splicing factor junctions are upregulated upon
(a)
(b)
Upregulated Unregulated Downregulated
Junctions 14,056 (14 %) 72,499 (74 %) 11,311 (12 %)
Genes 6,256 (30 %) 9,156 (44 %) 5,501 (26 %)
Junctions 25,534 (20 %) 84,901 (68 %) 14,793 (12 %)
Genes 7,997 (33 %) 9,932 (41 %) 6,580 (27 %)
Junctions 2,257 (4 %) 49,583 (94 %) 989 (2 %)
Genes 1,689 (16 %) 7,736 (75 %) 885 (9 %)
Junctions 1,733 (44 %) 1,705 (43 %) 524 (13 %)
Genes 1,272 (45 %) 1,135 (40 %) 449 (16 %)
Junctions 5,962 (43 %) 5,725 (41 %) 2,180 (16 %)
Genes 3,062 (43 %) 2,581 (37 %) 1,401 (20 %)
Junctions 516 (41 %) 720 (57 %) 32 (3 %)
Genes 448 (45 %) 507 (51 %) 32 (3 %)
Liver
Common
BMM
PTC+ junctions
All junctions
Liver
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BMM
Major Gene Ontology for PTC+ genes
Liver KO
BMM KO
mRNA processing (Common genes)
Mitochondrial function (Liver-specific genes)
GTPase regulator activity (BMM-specific genes)
Junctions Genes
Figure 2 Number of regulated splicing and PTC occurrences in Upf2 KO tissues. (a) Splice junctions with a minimum of three reads in WT
or KO samples were grouped into upregulated (≥2-fold up in KO), downregulated (≥2-fold down in KO) or unregulated. Genes corresponding to
the junctions are also shown. Left: number of junctions and genes and percentage in parentheses for the relative fraction in each tissue. The top
half of the table lists results for all junctions, the bottom half for PTC+ junctions only. Right: pie charts visualize the relative distribution of
regulated junctions and corresponding genes. (b) Venn diagram of major Gene Ontology terms associated with liver-unique genes (top), BMM-
unique genes (bottom) and common genes (overlap).
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muting NMD is in agreement with earlier studies
[7,18,19,32]. We also determined the GO terms asso-
ciated with genes containing upregulated PTC+ junc-
tions unique to either liver or BMMs (Figure 2b). In the
BMM-specific set, genes involved in G-protein coupled
receptor function were enriched (P-value 1.5 × 10-4,
Bonferroni corrected; Table S4 in Additional file 5),
whereas the liver specific set was strongly associated
with mitochondrion, among others (P-value 9.7 × 10-56,
Bonferroni corrected; Table S4 in Additional file 5).
In summary, we find that 43 to 44% of all predicted
PTC+ junctions are upregulated in Upf2-ablated tissues
and that 516 of these junctions are common in BMM
and liver, several of which are well-known NMD targets.
Moreover, we show that NMD is predicted to downre-
gulate isoforms of 16 to 28% of all expressed genes
(excluding the well-described regulation of splicing fac-
tors from the analysis). Moreover, NMD regulates genes
involved in mitochondria and G-protein-coupled recep-
tor functions in liver and BMM, respectively, suggesting
that NMD also serves tissue-specific functions.
Loss of NMD leads to the selective stabilization of
alternative splicing events
We next compared the impact of ablating NMD on
canonical versus AS in more detail. Here, a canonical
junction is defined as a splicing junction between two
consecutive exons of the longest RefSeq isoform for
each gene, and AS junctions are thus all other combina-
tions. In total, our pipeline detected approximately
10,000 unique AS junctions in BMMs compared to
approximately 35,000 in the liver (Figure 3). A signifi-
cant challenge in analyzing expression changes upon
NMD ablation is to distinguish primary from secondary
effects. Using the sensitive PTC-detection in RAIN-
MAN, we found that close to 50% of AS was predicted
to generate a PTC (Figure 3a, bottom), which is in stark
contrast to canonical splicing junctions (Figure 3a, top).
This suggests that NMD directly degrades 16% (0.47 ×
0.35) of all AS in BMMs and 18% in liver (0.45 × 0.39),
resulting in more than a two-fold reduction of the
involved isoforms.
The BMM and liver samples demonstrated essentially
similar fractions of up- and downregulated AS junctions
(Figure 3a). However, the number of unique AS junc-
tions were higher in liver samples, even after calibrating
for the number of mapped junction reads (and thereby
sequencing depth; Figure 3b, top). To investigate
whether this was a characteristic feature of the organs
or whether it was due primarily to muting of NMD, we
analyzed the AS complexity per gene (Figure 3b). The
number of mapped junction reads was first normalized
to BMM WT (Figure 1a) by stochastically removing
reads from BMM KO, liver WT and liver KO, to
exclude any skewing due to differences in sequencing
depth. Interestingly, these data demonstrate an inher-
ently different AS profile between the two tissues.
Whereas BMM WT and KO showed similar proportions
of AS, measured as the correlation between the number
of AS junctions and the total number of junctions per
gene (Figure 3b, top), the proportion of AS of the liver
KO sample increased considerably more compared to
both BMM KO and liver WT (Figure 3b, top). This
strongly suggests that the liver has a high level of AS
relative to BMM, both normally and through ablation of
NMD.
Finally, we also compared the proportion of PTC+
junctions, measured as the number of PTC+ junctions
as a function of total splicing for each gene (Figure 3b,
bottom). The PTC+ junctions followed the same trend
as for AS junctions, with a steeper relative increase in
PTC+ junctions in liver KO compared to liver WT and
BMM. From linear interpolation, we found that, on
average, 27% of all spliced junctions in a given gene in
the liver are predicted to result in a PTC (liver KO
slope of 0.27; Figure 3b).
In conclusion, these data demonstrate that approxi-
mately 17% of all AS is downregulated via NMD more
than two-fold. We furthermore show that liver is char-
acterized by a high degree of AS compared to BMMs
and that close to one-third of all uniquely spliced junc-
tions in the liver are predicted to elicit a PTC, thus giv-
ing the first in vivo evidence of the pervasive effect and
importance of AS-NMD in the mammalian organism.
Splice isoform classes are differently affected by NMD
ablation
As described above, we detected a significant increase
in AS upon ablating UPF2. It has, however, not pre-
viously been described to what extent NMD affects dif-
ferent splicing classes. Transcriptome-wide studies
where NMD has been muted have primarily looked at
single cassette exon skipping (ES) events [28,32], thus
disregarding many physiologically relevant AS events.
To this end, we implemented an AS isoform classifica-
tion module that allowed us to infer the degree to
which all major splice isoform classes were affected by
NMD. Hence, our splice isoform inference pipeline
assessed the distribution of splice junctions to seven
major groups of AS events, namely single exon skip-
ping (SES) and multiple exon skipping (MES), alterna-
tive 5’ splice site (A5SS) and alternative 3’ splice site
(A3SS), mutually exclusive exons (MXE), alternative
first exon (AFE) and alternative last exon (ALE) (see
Table 1, Supplementary Materials in Additional file 1
and Table S6 in Additional file 6 for pipeline perfor-
mance). We narrowed our downstream splice isoform
analysis to those that demonstrated a change in
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‘percent spliced in’ (PSI) between KO and WT (ΔPSI)
higher than 20%. PSI is calculated from the ratio of
junctions supporting a given feature (for example, the
inclusion of an exon) versus junctions supporting the
reciprocal event (for example, the skipping of the same
exon), and the ΔPSI is thus a metric of how much the
inclusion changes upon NMD ablation (see Supplemen-
tary Methods in Additional file 1 for further details).
We found that approximately 40% of all ES events with
a ΔPSI higher than 20% (inclusion) or lower than -20%
(exclusion) in the KO tissues were upregulated due to
stabilization of a PTC+ isoform (Table 1). Next, we
subdivided ES events into PTC upon inclusion and
exclusion events. An example of a PTC upon exclusion
event that is stabilized upon NMD ablation in both
BMM (ΔPSI = -61%) and liver (ΔPSI = -63%) is Mgea5,
which was also found upregulated in immortalized
mouse embryonic fibroblasts (MEFs) ablated for NMD
[32]. We validated this Mgea5 isoform among others by
RT-PCR (Figure 4b). In the liver, 55% of all single exon
inclusion events generated a PTC, whereas 40% were
found in the BMM (compare PTC upon inclusion to
total inclusion events for single ES in Table 1).
Tmem183a is an example of a highly skipped PTC
upon inclusion that was found stabilized in both BMM
(ΔPSI = 51%), liver (ΔPSI = 54%) and immortalized
MEFs ablated for NMD [32], and was similarly vali-
dated by RT-PCR (Figure 4b).
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Figure 3 Loss of UPF2 leads to increased AS-NMD. (a) Proportions of regulated canonical junctions versus junctions supporting AS events
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percentage of PTC+ junctions versus PTC- junctions (junctions that do not elicit a PTC) of upregulated junctions (black, PTC+; grey, PTC-). (b) The
number of AS junctions and the number of PTC+ junctions are shown as a function of number of junctions per gene in the top and bottom
panels, respectively. The slopes of the curves were calculated by linear interpolation. In total, our pipeline detected 10,061 unique AS junctions in
BMMs (8,107 in WT and 9,447 in KO) compared to 33,164 in the liver (25,390 in WT and 31,041 in KO), and calculations in the table (top) show
the number of unique AS junctions per million mapped reads for each sample. No minimum read cutoff was used in (b).
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Interestingly, for alternative usage of A5SSs and A3SSs,
we saw an even higher proportion of PTC+ events,
especially in the liver (compare the fourth and fifth rows
in BMM versus liver tissue in Table 1), suggesting a pre-
viously unrecognized importance for these splice events
in AS-NMD. The ribosomal protein Rps12 is an exam-
ple of a gene that generates a PTC+ isoform as a result
of A5SS in both BMM (ΔPSI = 50%) and liver (ΔPSI =
55%), and likewise for Smg5 in BMM (ΔPSI = 37%) and
liver (ΔPSI = 50%) as a result of A3SS (Table 1).
Using stringent criteria (Supplementary Methods in
Additional file 1), we detected 44 MXE events in the
BMM KO, but more than 10 times as many in the more
splice-prone liver KO tissue (Table 1). Out of the
detected MXE events, few were predicted to elicit a
PTC+ isoform, possibly due to the regulated nature of a
mutually exclusive splice event, which in most instances
would not be predicted to undergo NMD. An exception
is the pyruvate kinase gene Pkm2, which encodes two
different enzymatic active isoforms due to a single MXE
event [33]. In the KO samples, and this was particularly
true for BMMs, aberrant splicing resulted in inclusion
of both mutually exclusive exons, resulting in a PTC+
isoform (validation in Figure 4b and schematic in Figure
4d). This may indicate an important role for NMD in
ensuring the exclusive incorporation of exons in MXE
events.
Finally, we quantified the number of isoforms with an
increase in AFE or ALE. From transcriptome data alone,
it is often impossible to determine whether an AFE is
the result of alternative promoter usage or AS between
two mutually exclusive first exons and the second exon.
Nevertheless, AFE results in alternative transcripts with
potential PTCs. Analysis of AFE showed that more than
one-third of the detected AFE events are predicted to
generate a PTC+ isoform (Table 1). For ALE categoriza-
tion, we required AS to two mutually exclusive 3’ term-
inal exons, and PTC+ prediction is thus not meaningful.
Hence, changes in levels of ALE are therefore most
likely secondary effects of altered splicing upon UPF2
ablation. A functional mechanism for ALE is the regu-
lated inclusion of microRNA target sites in the 3’ UTR,
and this potentially adds another layer of complexity
when studying conditions where splicing is perturbed,
such as by removing NMD.
To test the accuracy of our splice isoform detection
algorithm, we chose 50 RAINMAN-predicted AS events
(ΔPSI > 20% (inclusion), or < -20% (exclusion)) for RT-
PCR on independent liver and BMM material. We vali-
dated AS events that are not predicted to result in a
PTC+ isoform (Figure 4b, top row), isoforms stabilized
in the KO due to inclusion of a PTC (Figure 4b, middle
row) and isoforms that elicit a PTC due to a skipping
event (Figure 4b, bottom row). Out of the 50 tested AS
events, we were able to validate 49 of these (98%), and
we therefore conclude that our splice isoform detection
algorithm is highly accurate in predicting different splice
isoform events.
To validate the inferred expression changes and to
assess inter sample-replicate variability, we performed
quantitative PCR experiments on biological replicates.
This analysis showed a strong correlation with the
Table 1 Splice events and PTC+ classification
Tissue Splice
event
Total
events
PTC+
events
Percentage PTC
+
Exclusion
events
PTC upon
exclusion
Inclusion
events
PTC upon
inclusion
BMM Total ES 730 281 38% 428 201 302 80
Single ES 511 310 148 201 80
Multiple ES 219 118 53 101 -
A5SS 130 68 52%
A3SS 238 110 46%
MXE 44 5 11%
AFE 130 44 34%
ALE 49 NA NA
Liver Total ES 3,102 1,285 41% 1,926 965 1,176 320
Single ES 1,505 932 531 573 320
Multiple ES 1,597 994 434 603 -
A5SS 449 263 59%
A3SS 654 370 57%
MXE 475 66 14%
AFE 172 66 38%
ALE 143 NA NA
Splice isoform classes are shown for both single and multiple exon skipping (ES), alternative 5’ splice site (A5SS), alternative 3’ splice site (A3SS), mutually
exclusive exons (MXE), alternative first exon (AFE) and alternative last exon (ALE). For ALE, no events were classified as PTC+, since the class relies on splicing to
two different last exons. Here, a ΔPSI > 20% was required for all classes. NA, not applicable.
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Figure 4 Splice isoform classes are differentially affected by loss of UPF2. (a) Schematic drawing of the main isoform classes detected in
our pipeline. (b) RT-PCR validation of 25 splicing events predicted from our pipeline (see Table S9 in Additional file 12 for a list of the 49
validated events out of 50 tested). Top: normal AS events. Middle: PTC upon inclusion events. Bottom: PTC upon exclusion by ES. (c) Western
blotting from two different liver pairs, showing UPF2 (rabbit a-UPF2), SRp55, SRp40 and SRp30 (mouse a-mAb104) and b-actin (rabbit a-actin).
The asterisk denotes the truncated UPF2 isoform found in cells ablated for NMD. (d) MXE splicing of Pkm2 and the inclusion of both mutually
exclusive exons in the KO sample.
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RNA-seq inferred expression changes (R = 0.975, Pear-
son’s correlation; Figure S3A in Additional file 7) and a
very low sample replicate variability (Figure S3B in
Additional file 7). In addition, we assessed our ability to
correctly infer PTC+ isoforms by cloning and sequen-
cing the full-length isoforms of Srsf9, a gene with a
PTC-upon inclusion event (ΔPSI = -40% in liver; iso-
form not detectable in BMMs). The predicted PTC+
isoform was precisely recapitulated in vivo (Figure S3C
in Additional file 7), further validating the usefulness of
our approach.
Loss of NMD leads to deregulation of PTC- isoforms
through breakdown of splice factor homeostasis
We have demonstrated that only 50% of upregulated AS
junctions are predicted to be the direct result of stabi-
lized PTC+ isoforms, suggesting that a major proportion
of the increased AS is the indirect result of perturbed
NMD (Figure 3a). As we have shown here, the liver has
a high degree of AS (Figures 1 to 3), and it has been
found to have a prominent divergent expression pattern
of SR proteins and hnRNPs compared to other mamma-
lian tissues [34]. Hence, we hypothesize that this could
make the liver particularly susceptible to changes in
splicing patterns upon ablation of NMD.
Splicing factors are known to utilize AS-NMD to
autoregulate their own synthesis in a negative feedback
loop, through the selective inclusion or exclusion of
PTC+ exons [4,18]. Indeed, our RNA-seq analysis also
identifies a range of these factors among the core NMD
targets (Figure 2; Table S3 in Additional file 4). How-
ever, as most of the NMD sensitive splicing factor iso-
forms are predicted to encode truncated proteins, the
rescue of these upon NMD ablation is not expected to
affect AS per se (unless they encode proteins with domi-
nant negative properties). Previous microarray-based
studies have not addressed the formal possibility that
the stabilization of PTC+ isoforms upon loss of NMD
could occur against the backdrop of changed levels of
the canonical isoforms capable of encoding the full-
length form of proteins such as splicing regulators. To
test this possibility, we scrutinized our datasets for
changes in the expression levels of 25 canonical mRNA
isoforms capable of encoding full-length splicing regula-
tors by correcting the changes in the gene expression
ratios between KO and WT samples with the fraction
contributed by the PTC+ isoforms (Table S5 in Addi-
tional file 1). Strikingly, for the 19 splice factors for
which we have evidence for AS-NMD in the liver, 10
displayed a > 1.5-fold deregulation, with 5 displaying
increased (Sfrs3, Srfs4, Tra2a, Srfs16, Hnrpdl) and 5
decreased (Tra2b, Hnrnpf, Hnrnph3, Hnrnpr, Ptbp2)
expression of the canonical mRNA isoforms. Moreover,
western blot analysis revealed that SRp30 and SRp40
protein levels were elevated in KO liver, demonstrating
that the changes in canonical mRNA isoform levels for
at least some splicing factors are indeed translated into
full-length protein.
Collectively, these findings support a model where the
increase in global AS upon loss of NMD is at least in
part caused by a massive deregulation of key splicing
factors, and further help to explain the PTC- AS frac-
tion deregulated upon muting NMD. A highly aberrant
level of splice regulators would likely tilt the normal bal-
ance between activators and repressors and deregulate a
large subset of exons [4,18].
Ablating NMD leads to skipping of highly conserved
cassette exons
SES represents the best characterized AS event, and is a
frequent PTC-generating mechanism. RAINMAN classi-
fied 40% and 60% of all SES as PTC+ events in the
BMM and liver KO samples (Table 1 - compare PTC
upon exclusion with total exclusion events, and PTC
upon inclusion with total inclusion events). Out of the
PTC upon inclusion events, a total of 26 events were
upregulated in both KO tissues (ΔPSI > 20%) and 51
PTC upon exclusion events were similarly upregulated
in both KO tissues (ΔPSI < -20%; manually curated lists
are included in Table S7 in Additional file 8 and Table
S8 in Additional file 9). In support of an important phy-
siological function, almost all of the genes harboring
these highly upregulated PTC+ isoforms were also upre-
gulated at the gene level in KO samples (Table S7 in
Additional file 8 and Table S8 in Additional file 9), sug-
gesting that stabilization of the PTC+ isoforms led to an
appreciable increase in total mRNA levels in KO tissues.
It should be noted that most of the splicing factors and
ribosomal proteins known to use AS-NMD were indeed
upregulated in both tissues, but had ΔPSI > -20% or <
20% in BMMs (data not shown). Hence, the high fre-
quency of PTC+ splice events suggests that these are
regulated AS events. It is generally found that AS exons
are more conserved than constitutive exons, especially
in the flanking introns [35]. The core members of the
SR protein family and hnRNPs have been proposed to
use AS-NMD in an autoregulatory loop, by binding to
highly conserved regions, termed ultraconserved ele-
ments (UCEs), to elicit the PTC+ splice event [18,20].
Upon inhibition of NMD in cell lines, it has been shown
that many PTC+ exons are surrounded by high intronic
conservation [18,19]. As described above, our sensitive
approach demonstrated a high proportion of PTC- AS
events upregulated in KO tissues, and we therefore
examined the conservation of PTC+ and PTC- single
exon exclusion (ΔPSI < -20%) and inclusion (ΔPSI >
20%) events in the KO samples compared to the unre-
gulated skipping events. The latter control group
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contains exons that undergo AS but are not differently
skipped between WT and KO (-20% < ΔPSI ≤ 20%). We
first examined exclusion events, and found that flanking
introns of the skipped exons are significantly more con-
served compared to unregulated skipping events (Figure
5a; P-value < 2.2 × 10-16, Komogorov-Smirnov test), and
this was even more pronounced in BMMs (Figure S4 in
Additional file 10). Interestingly, flanking introns of
PTC+ upon exclusion events were less conserved than
PTC- exclusion events, but displayed a significant higher
exonic conservation (P-value < 2.2 × 10-16, Komogorov-
Smirnov test). We next considered exons that demon-
strated increased inclusion in KO samples. In these
cases, flanking introns were also significantly more
highly conserved compared to skipping events not regu-
lated by NMD (Figure 5b). Again, PTC- inclusion events
were more highly conserved compared to PTC+ events
in the flanking introns.
In summary, these results demonstrate that 40 to 60% of
upregulated SES events are predicted to undergo NMD,
depending on tissue type, and that these splice events
are highly conserved. Importantly, PTC- inclusion and
exclusion events displayed higher intronic conservation
compared to PTC+ events, strongly suggesting that the
UCE-containing splice regulator isoforms (which are all
PTC+) are not the primary reason for the high intronic
conservation surrounding skipped exons. Moreover,
removal of UCE elements from the analysis did not alter
the intronic conservation profiles of either PTC- or PTC
+ events (data not shown). Thus, the high conservation
for both included and excluded exons appears to be a
general attribute of highly regulated cassette exons
(ΔPSI > 20%) that are affected directly and indirectly by
NMD. Thus, the deregulation of PTC- events is there-
fore consistent with a mechanism where deregulated
levels of splice regulators in the KO samples markedly
affect regulated splicing of their cognate target exons.
This again implies that ablating Upf2, and by inference
NMD, has important secondary effects on splicing factor
homeostasis and that this impacts widely on global AS.
Muting NMD leads to increase in splicing by-products
We have demonstrated that removing UPF2, and by
inference NMD, causes a dramatic increase in AS, in
part by stabilizing PTC+ AS isoforms. Apart from AS-
NMD, NMD has been implicated in removal of genomic
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Figure 5 Introns flanking regulated exons are highly conserved. (a, b) Mean per position phastCon conservation scores around SES events
are shown for exclusion events upregulated in the KO sample (a), and for inclusion events upregulated in the KO sample (b). Shown are PTC+
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noise and splice errors that might otherwise lead to a
panoply of spurious isoforms [7,36-38]. The extent to
which NMD destroys such splice by-products has not,
however, been studied on a transcriptome-wide basis in
mammalian tissues. We therefore examined the relative
expression level of PTC+ junctions, measured as the
PTC+ fraction (PTC-generating junctions/All other
junctions) against the junction expression level (Figure
6), binned by the RNA-seq metric RPKM (reads per kb
of gene model per Mb of mapped reads, refer to [39]).
These data show that the PTC+ fraction is enriched in
liver compared to BMM over the entire expression pro-
file, further emphasizing that the liver is characterized
by an increased abundance of PTC+ isoforms compared
to BMM. Importantly, there is a distinct overrepresenta-
tion of PTC+ isoforms in the lower expression range for
both liver (Figure 6 - compare dark red and light red for
liver KO and WT, respectively) and BMM (Figure 6 -
compare dark blue with light blue for BMM KO and
WT, respectively) relative to more highly expressed iso-
forms. These data thus confirm and quantify, on a glo-
bal scale, another major role for NMD in removing low-
abundance isoforms such as the products of erroneous
splicing.
PTC exons are distinct from normal stop codon exons
We have shown that NMD-affected SES events demon-
strate a high conservation score and that this is not due
to UCE-containing SR proteins and hnRNPs. The ques-
tion then arises to what extent the PTC+ exon itself is
aberrant compared to other expressed exons, and in
particular the normal stop codon-containing exon. We
thus examined the conservation of the exonic sequence
surrounding the PTC in upregulated PTC+ exons, as
evidenced by upregulated PTC+ junctions. To normalize
for normal exonic conservation variation and for biases
in tissue-specific exon conservation, we subtracted ran-
dom exonic sequences expressed in the same samples.
Interestingly, we found that PTC+ exons had a markedly
different conservation profile compared to normal stop
codon exons (Figure 7a; for comparison, see unnorma-
lized conservation score in Figure S5 in Additional file
11). Hence, exonic sequence conservation increased
towards the PTC, and displayed only a minor drop in
relative conservation score in nucleotides following the
PTC. Importantly, the PTC and surrounding nucleotides
displayed an overall higher conservation score relative to
random exons, and this was particularly striking for
PTCs in BMM. Notably, removal of the UCE-containing
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significance.
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core splicing factor genes did not influence the conser-
vation profile in liver or BMM (data not shown). The
BMMs are characterized by a more stringent splice pat-
tern, whereas the liver has a high degree of AS and
increased PTC+ junctions expressed at low levels (Fig-
ures 2 to 4 and 6), pointing to an increased fraction of
random splice byproducts in the liver. Hence, the
increased PTC+ exonic conservation in BMMs com-
pared to the liver is likely due to a higher proportion of
functionally relevant PTCs in BMMs, found in various
vertebrates. Moreover, the relatively high conservation
score at and after the PTC suggests that these sequences
may possibly harbor un-recognized cis elements that
could assist in recognizing the PTC.
Finally, we also gauged whether PTCs associated with
highly regulated PTC-inducing junctions displayed any
preference for the identity of the stop codon (Figure
7b). Surprisingly, whereas the frequencies of normal
canonical UAA, UAG and UGA RefSeq stop codons
corresponded closely to the distribution observed in
exonic regions, regulated PTCs had a marked and highly
significant preference for UGA in both tissues. These
findings suggest that the NMD eliciting PTCs have been
under selective pressure in order to adapt to the regula-
tory needs of AS-NMD.
Discussion
Here, we present the first RNA-seq study from geneti-
cally modified adult mice accompanied by a thorough
comparative study of the role of NMD in two distinct
murine tissues. Moreover, this is the first analysis to
date of the global impact of NMD on all major classes
of AS in untransformed mammalian cells.
To facilitate a detailed analysis of AS, we have gener-
ated a streamlined bioinformatic pipeline, RAINMAN,
available to the scientific community, that maps RNA-
seq reads to a comprehensive combinatorial exon-exon
junction database to obtain maximum AS isoform infor-
mation. This method allowed us to map 28% of all map-
pable reads to junctions (all samples combined; Figure
1) with a total discovery of 150,000 unique junctions,
thus giving us high AS information. The junction data
are further processed in the pipeline to predict NMD
susceptibility and thus coding potential with high accu-
racy at single junction resolution. Finally, seven major
splice isoform classes are inferred and processed for
multiple comparison purposes.
Loss of NMD leads to a pronounced deregulation of
alternative splicing
Using this pipeline, we have shown that ablating Upf2,
and by inference NMD, impacts on several layers of AS
in both BMMs and liver. By examining genes that harbor
the exact same spliced junctions predicted to elicit a PTC
in both tissues, our data confirmed that genes involved in
mRNA processing are highly overrepresented among
common NMD targets, as previously shown (Table S3 in
Additional file 4). From our data, we estimate that close
to one-third of all junction events supporting AS result
in PTC+ and NMD-sensitive transcripts in the liver (Fig-
ure 3b), which is in agreement with earlier predictions
[4]. Previous computational analyses of dbEST and
SWISS-PROT have found that 8 to 12% of human genes
are predicted to be targets of NMD [4,40], but these
repositories inherently underestimate the true number of
NMD-sensitive isoforms. Our data demonstrated that
16% and 28% of expressed genes in BMM and liver,
respectively, were predicted to undergo NMD (upregu-
lated more than two-fold in KO) of one or more iso-
forms. These numbers expand upon and underscore the
global importance of NMD and in particular AS-NMD.
Nearly all detected PTC+ events could be attributed to
AS, and we found that approximately 50% of all AS in
the KO was in fact predicted to elicit a PTC (Figure 3a),
with the liver as the tissue with the most AS (Figure 3b).
This complements previous findings showing that the
liver has one of the highest levels of AS compared to
other organs [2,34]. The high level of AS in the liver was
also reflected in the fraction of low-level PTC+ junctions
(Figure 6), most likely consisting of splice errors. Thus,
our data make a strong case for NMD playing an impor-
tant role in removing ‘splicing’ noise also in untrans-
formed mammalian tissues.
In contrast to the splice error-generated PTC+ iso-
forms, our analysis of highly regulated splice classes
(ΔPSI > 20% or ΔPSI < -20%), revealed that approxi-
mately 40% of all highly skipped exons were degraded
by NMD (Table 1). These ES events were further subdi-
vided into SES and MES events. Whereas three-quarters
of all ES events in BMMs were SES, the proportion of
SES and MES in liver was approximately equal. We
speculate that the increased MES proportion reflects the
more promiscuous splicing pattern in the liver, thus
leading to novel AS between exons not normally spliced
together.
Importantly, our analysis of conservation patterns in
SES revealed a high conservation score of NMD-regu-
lated skipping exons and their flanking introns com-
pared to that of unregulated events. This suggests that
events deregulated in the absence of NMD are under
tight control in normal NMD-proficient cells and that
AS-NMD plays a crucial role in controlling the expres-
sion of a vast number of genes.
The splice isoform inference analysis expands the
repertoire of NMD targets
From our splice isoform inference, we found a high pro-
portion of PTC+ events in most classes with the notable
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exception of MXEs (ALE events were not included in
PTC classification). Due to the regulatory nature of
MXEs, in which two coding exons compete for the
selective inclusion, it is not surprising that this group is
underrepresented in the PTC+ events. One interesting
example was Pkm2, in which a well-characterized MXE
event either dictates whether the adult form (M1 iso-
form containing exon 9) or the embryonic isoform (M2
containing exon 10) is produced. In many tumors, the
embryonic M2 isoform is switched on, leading to
increased aerobic glycolysis [33]. However, we found
that ablating UPF2, and by inference NMD, led to inclu-
sion of both mutually exclusive exons with a resulting
downstream PTC (Figure 4b, d), suggesting an interest-
ing function for NMD in controlling MXE. We also pro-
vide the first report of a surprisingly high frequency of
PTC+ A5SS and A3SS events, suggesting that the alter-
native usage of splice acceptor or donor sites is often
utilized to regulate expression by AS-NMD. Another
possibility could be that these events are more error-
prone - for example, by the use of a strong and weak
splice site (the alternative splice site), leading to a less
stringent AS than between two strong splice sites such
as SES. Nevertheless, our study significantly expands the
known repertoire of NMD targets in all classes of AS,
many previously uninvestigated on a global scale.
Common and tissue-specific functions of NMD
The impact of NMD on transcriptome composition has
up to now only been studied in whole organisms or
individual cell lines, which has therefore precluded any
insights into conserved versus tissue-specific functions
of NMD. Focusing first on core NMD targets, our strin-
gent comparative analysis found 50 genes with a com-
mon highly upregulated PTC upon exon exclusion in
BMMs and liver (Table S8 in Additional file 9). Almost
all of these genes were upregulated in both tissues, sug-
gesting a functional role for AS-NMD in regulating the
abundance of transcripts with full coding potential from
these genes (see below). Several of the known splicing
factors previously shown to utilize AS-NMD in an auto-
regulatory loop, such as Ptbp1, demonstrated PTC upon
exclusion in both tissues, but below ΔPSI of 20% in
BMMs. Besides SR proteins and hnRNPs, most of the
genes found upregulated are unknown targets for AS-
NMD, such as Soat2/and Acat2. The latter gene is
involved in esterification of cholesterol, and is known to
be regulated in a tissue-specific manner, with a particu-
larly high expression level in liver and intestine and to a
lesser extent in macrophages [41]. Here, we found that
this gene was upregulated 8.4-fold in BMMs and 4.2-
fold in liver upon muting NMD, suggesting an impor-
tant regulatory function for AS-NMD in the synthesis of
cholesterol esters.
We found 26 genes with a common PTC upon inclu-
sion event (ΔPSI > 20%) in both BMM and liver KO
(Table S7 in Additional file 8). An example of a gene
with a PTC upon inclusion isoform is Nktr, which is
exclusively expressed in and required for natural killer
(NK) cells. We found that inhibiting NMD caused a
high upregulation of a PTC+ isoform and a concomitant
2.4- to 3.9-fold upregulation at the gene level. It has
been shown that aberrant isoforms of the Nktr gene are
present in cells not expressing Nktr [42]. Here, we show
that NMD mutes Nktr in BMMs and liver (and also in
NMD ablated transformed MEFs [32]), suggesting that
AS-NMD serves an important regulatory function in
regulating the functional expression of this NK cell-spe-
cific protein. Interestingly, Nktr is involved in NK cell
activity but contains RS repeats and a cyclophilin-
domain found in several splicing factors, and this could
confer on the protein properties sufficient to facilitate
regulation of its own expression through AS-NMD.
Thus, it could be that several other proteins not directly
involved in splicing have gained RNA-binding properties
that would allow them to autoregulate their own synth-
esis by AS-NMD.
Apart from the core NMD targets, our analysis also
yielded the first insights into potential tissue-specific
effects of NMD. Through GO analysis of parent genes
of PTC+ junctions that were exclusively upregulated in
either the BMM or liver datasets, we could show a tis-
sue-specific role for NMD in the regulation of G-pro-
tein-coupled receptors and mitochondria function,
respectively. Interestingly, these GO classes mirror the
main biological functions of monocytes/macrophages
and liver tissue, that is, in immunological reactions and
energy metabolism, respectively, and we predict that
NMD-dependent transcriptome analysis in other organs
would uncover tissue-specific NMD targets in pathways
of particular importance for the organ in question.
NMD controls the expression of a network of splicing
factors
In contrast to the well-characterized role of AS-NMD in
the autoregulation of individual splicing factors, the glo-
bal consequences of its disruption on broad splicing pat-
terns have not been studied in detail. We were therefore
intrigued by finding that approximately 50% of the upre-
gulated AS events in the NMD-deficient tissues were
devoid of PTCs, suggesting that they were indirect tar-
gets of NMD and that the importance of NMD in AS
extends well beyond AS-NMD.
Using conventional microarray-based gene expression
analysis, we have previously shown that several splice
factors were upregulated in both UPF2-deficient BMMs
and liver [30,43]. However, these studies could not dis-
criminate between canonical mRNA isoforms and
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stabilized PTC+ isoforms, which is important as many
of the latter would be predicted to encode truncated
and thereby (most likely) non-functional proteins. Using
our RNA-seq data, and correcting for the presence of
the PTC+ isoforms, we can now show deregulated
expression of the canonical mRNA isoform (encoding
the full-length protein) for a prominent number of
splice factors, a finding that was also corroborated by
changes in protein levels for two of these. These find-
ings suggest that the prominent deregulation of PTC-
containing events, at least in part, can be explained by
changes in the protein levels of splicing factors. This is
further supported by the observation that the intronic
regions surrounding deregulated PTC- exons are highly
conserved, suggesting that they are subjected to splice
factor-mediated regulation.
Our data therefore extend the importance of NMD to
the regulation of PTC-deficient mRNA isoforms through
the deregulation of splice factor levels. The mechanisms
(s) by which this occurs will be the subject of future stu-
dies. They also provide a clue as to why the liver is
more affected by the loss of NMD than BMMs, as the
former organ displays much higher levels of AS and is
therefore predicted to be more sensitive to alterations in
splicing factor levels.
Finally, and most importantly, these findings expand
the functional impact of NMD on transcriptome beha-
vior to also include substantial indirect effects on PTC-
splicing events and highlights the crucial importance of
this pathway as a gatekeeper of transcriptome integrity.
A role for the stop codon and its flanking regions in
regulating NMD
The importance of PTC identity and its flanking regions
in the regulation of NMD is a relatively unexplored area
and has not previously been addressed on a global scale.
Here we were able to show that regions flanking regu-
lated PTCs display a divergent and increased level of con-
servation when compared to both canonical stop codons
and exonic regions, suggesting that they have been under
selective pressure. Similarly, the distribution of regulated
PTCs was markedly different from that of normal termi-
nation events with a strong preference for the NMD
machinery to use UGA. This is interesting in light of
recent findings showing that sequences (including stop
codons) having positive impact on stop codon read-
through lead to a reduction of NMD through the removal
of UPF1 from the 3’ UTR through a translation-depen-
dent mechanism [44]. These findings may suggest that
the PTC and its surrounding sequences have been under
selective pressure to optimize NMD efficiency in a pro-
cess involving translational read-through, which in turn
may be used by the cell for regulatory purposes.
Conclusions
By developing and applying a robust bioinformatic pipe-
line mediating a high-resolution study of AS and its
dynamics, this whole-transcriptome analysis of two
NMD-deficient primary mouse tissues provides a com-
prehensive quantification of the impact of NMD on
untransformed mammalian transcriptomes, providing
crucial novel insights into its role in both core and tis-
sue-specific regulation of gene expression, significantly
extending the importance of NMD from an mRNA
quality pathway to a regulator of several layers of gene
expression. Thus, in addition to removing low levels of
splicing ‘errors’, and destabilizing targets of AS-NMD,
our analysis reveals the potentially crucial importance of
NMD in maintaining splicing homeostasis. In particular,
the observed deregulation of full-length splicing regula-
tors suggests that the NMD pathway controls their
expression in a manner distinct from direct AS-NMD,
and that their deregulation is an important contributor
to the global deregulation of AS that we observe in
NMD-deficient tissues.
Finally, we have provided a reference catalogue of
NMD-regulated AS events as well as an open source
tool, RAINMAN, facilitating the process of splice iso-
form inference and PTC prediction from RNA-seq
reads. Future transcriptome studies in other organs and
organisms will further reveal the impact of NMD on
splicing patterns and how this pathway modulates biolo-
gical read-out in a tissue- and pathway-specific manner.
Materials and methods
Mice
For the selective deletion of UPF2 in liver and BMM we
used our conditional floxed Upf2 line and the LysMCre
and Mx1Cre driver lines as described previously [7].
Upf2 is recombined during macrophage differentiation,
and the mature BMMs are devoid of any functional
UPF2 protein as well as NMD activity. To rescue the
Upf2fl/fl; Mx1Cre from the previously reported hemato-
poietic lethality, Upf2fl/fl; Mx1Cre and Upf2fl/fl were
transplanted with wild-type bone marrow cells prior to
poly-I:C injection. As described previously, liver was
harvested 3 weeks after Upf2 recombination to avoid
any indirect effects from the poly-I:C treatment [30]. All
mouse work was performed according to national and
international guidelines and approved by the Danish
Animal Ethical Committee. This study was approved by
the review board at the Faculty of Health, University of
Copenhagen (LT-P0658).
cDNA synthesis for RNA-seq
Total RNA was harvested in Trizol (Invitrogen; Carlsbad,
CA, USA from Upf2fl/fl; LysMCre and Upf2fl/fl-derived
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male BMMs, grown as previously described [7]. Briefly,
bone marrow cells were grown in vitro in the presence of
macrophage colony-stimulating factor-conditioned med-
ium for 7 days, giving essentially a 100% pure macrophage
population. Total RNA from liver was harvested in Trizol
21 days after injection of poly I:C from Upf2fl/fl; Mx1Cre
and Upf2fl/fl; Mx1Cre. We pooled 50 μg RNA from each of
three age-matched males to get a total of 150 μg RNA,
which was subjected to two rounds of mRNA purification
by hybridizing to oligo(dT) beads (Dynabeads mRNA puri-
fication kit, Invitrogen). The resulting mRNA (1 μg) was
then used as template to prepare cDNA. Double-stranded
cDNA was essentially prepared as described by the manu-
facturer (Superscript Double-Stranded cDNA Synthesis
kit, Invitrogen), using 10 μM random hexamers to prime
first strand synthesis. Finally, the double-stranded cDNA
was purified using QiaQuick PCR columns (Qiagen, Hil-
den, Germany) followed by phenol-chloroform extraction.
The quality of the cDNA was verified using a Bioanalyzer.
Library preparation for cDNA sequencing was per-
formed essentially as for the whole genome DNA library
construction (DNA sample prep kit, Illumina; see Sup-
plementary Methods in Additional file 1). Sequencing
was performed on an Illumina Genome Analyzer II
flowcell, generating 75 bp single-end reads. RNA-seq
data have been submitted to the NCBI Short Read
Archive database with accession number GSE26561.
RT-PCR and western blotting
Total RNA was purified using Trizol and 0.5 μg RNA
was used to synthesize single-stranded cDNA with oligo
d(T) primers, using a ProtoScript M-MULV First-Strand
Synthesis kit (New England Biolabs, Ipswich, MA, USA)
as described by the manufacturer. The cDNA was used
in standard PCR reactions using Taq Polymerase (Invi-
trogen), with primers specific for the exons flanking the
alternative exon (see Table S9 in Additional file 12 for a
list of primers). For protein analysis, snap-frozen tissue
was dissected and lysed in ice-cold RIPA buffer supple-
mented with proteinase inhibitors and separated by
SDS-PAGE and subjected to western blotting. Antibo-
dies used: affinity-purified rabbit a-UPF2 (kind gift from
Dr Jens Lykke-Andersen); rabbit a-mAb104 serum
(pan-SR protein antibody; kind gift from Dr Javier
Caceres); mouse a-b actin (ab6276, Abcam, Cambridge,
UK). Development of a-mAb104 immunoblotted liver
protein lysate required different exposure times depend-
ing on the molecular weight band, and was thus treated
individually for the different protein bands.
RAINMAN overview
Figure S1B in Additional file 2 outlines the sequential
bioinformatic processing steps making up the RAIN-
MAN pipeline utilized in this study. Our PTC and splice
event detection and quantification pipeline is available
as a series of Python and R scripts, readily scalable and
customizable for use with RNA-seq short reads of any
length. First, an index is generated, consisting of the
relevant genome assembly combined with a combinator-
ial exon-exon junction database, as described in detail in
the Supplementary Methods in Additional file 1. Reads
are mapped to this index (using the Bowtie/TopHat
[31,39] mappers as default) and unmapped reads are
truncated to rescue reads spanning more than two
exons. Gene expression is calculated by the RPKM
metric (analogous to fragments per kb of exon per mil-
lion fragments mapped (FPKM)) using the Cufflinks
package [45] and upper quartile normalization, and
junction expression levels are calculated by quantifying
reads spanning exon-exon boundaries, likewise using the
RPKM metric, and are (optionally) normalized using
“Trimmed mean of M component” (TMM) normaliza-
tion [46]. Finally, junctions are processed by PTC and
splice event detection algorithms, and all data are out-
put, allowing the researcher to visualize results in UCSC
Genome Browser and spreadsheet software. See Supple-
mentary Methods in Additional file 1 for a detailed
description of RAINMAN and Table S6 in Additional
file 6 for splice detection validation. RAINMAN scripts,
documentation and complete junction and gene expres-
sion lists are available online [47].
Statistical methods
The statistical package R was used to calculate Chi-
square and Kolmogorov-Smirnov tests.
Database accession
RNA-seq data are available at the NCBI Short Read
Archive database (accession number GSE26561). RAIN-
MAN scripts, documentation and complete junction and
gene expression lists are available online [47].
Additional material
Additional file 1: Supplementary Information and Supplementary
Tables S1, S2 and S5. Supplementary Materials, Methods and
References. Supplementary Table S1: number of mapped junctions
contributed uniquely by the combinatorial database (Comb DB only) or
TopHat (TopHat only) and the number of mapped junctions detected by
both the combinatorial database and TopHat (Both). Supplementary
Table S2: the contribution of TopHat to the number of junctions
predicted to generate a PTC versus all junctions (minimum of three reads
per junction). Supplementary Table S5: deregulation of core splice factors.
Gene FC indicates the change in mRNA levels for all the isoforms for the
particular gene between KO and WT.
Additional file 2: Supplementary Figure S1. UCSC Genome browser
output of Pion gene and schematic of the RAINMAN pipeline with steps
for mapping and processing of reads.
Additional file 3: Supplementary Figure S2. Histogram showing
distance from normal stop codon to the 3’ end of RefSeq genes with
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stops in final exon, and distances to nearest downstream exon-exon
junction for genes with stop codons in the second to last exon.
Additional file 4: Supplementary Table S3. Reads per unique junction
statistics for all samples, split into junctions discovered by mapping to
the combinatorial database versus junctions discovered by TopHat.
Additional file 5: Supplementary Table S4. Table with Gene Ontology
terms associated with genes containing upregulated PTC+ junctions that
are unique for Upf2 KO liver or BMM.
Additional file 6: Supplementary Table S6. Results from validation by
manual inspection of output from isoform class inference.
Additional file 7: Supplementary Figure S3. Validation of expression
change inference and isoform inference.
Additional file 8: Supplementary Table S7. PTC upon inclusion
isoforms (SES) upregulated in both Upf2 KO liver and BMM (ΔPSI > 20%).
Additional file 9: Supplementary Table S8. PTC upon exclusion
isoforms (SES) upregulated in both Upf2 KO liver and BMM (ΔPSI <
-20%).
Additional file 10: Supplementary Figure S4. Mean per position
phastCon conservation score around single exon skipping events for
BMMs. Numbers on x-axis indicate nucleotide intervals - 25 and 75
nucleotides for exons and flanking introns, respectively.
Additional file 11: Supplementary Figure S5. Conservation around
upregulated PTCs, with mean per-position phastCon scores centered on
the PTC for upregulated junctions in liver and BMMs.
Additional file 12: Supplementary Table S9. List of primers used in RT-
PCR validation of splicing events.
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